Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (12): 1165-1172.DOI: 10.3969/j.issn.1673-8640.2017.12.022
• Orginal Article • Previous Articles Next Articles
GUO Han, ZHANG Jie, YANG Shuo, QIAO Rui
Received:
2017-03-01
Online:
2017-12-30
Published:
2018-01-10
CLC Number:
GUO Han, ZHANG Jie, YANG Shuo, QIAO Rui. Research progress in the relationship between gut microbiome and human diseases[J]. Laboratory Medicine, 2017, 32(12): 1165-1172.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.12.022
[1] | HOOPER L V,GORDON J I.Commensal host-bacterial relationships in the gut[J]. Science,2001,292(5519):1115-1118. |
[2] | D'ARGENIO V,SALVATORE F. The role of the gut microbiome in the healthy adult status[J]. Clin Chim Acta,2015,451(Pt A):97-102. |
[3] | PALMER C,BIK E M,DIGIULIO D B,et al.Development of the human infant intestinal microbiota[J]. PLoS Biol,2007,5(7):e177. |
[4] | KOENIG J E,SPOR A,SCALFONE N,et al.Succession of microbial consortia in the developing infant gut microbiome[J]. Proc Natl Acad Sci U S A,2011,108(Suppl 1):4578-4585. |
[5] | BÄCKHED F,ROSWALL J,PENG Y,et al. Dynamics and stabilization of the human gut microbiome during the first year of life[J]. Cell Host Microbe,2015,17(5):690-703. |
[6] | MARIAT D,FIRMESSE O,LEVENEZ F,et al.The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age[J]. BMC Microbiol,2009,9:123. |
[7] | SUZUKI T A,WOROBEY M.Geographical variation of human gut microbial composition[J]. Biol Lett,2014,10(2):20131037. |
[8] | YATSUNENKO T,REY F E,MANARY M J,et al.Human gut microbiome viewed across age and geography[J]. Nature,2012,486(7402):222-227. |
[9] | DETHLEFSEN L,RELMAN D A.Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation[J]. Proc Natl Acad Sci U S A,2011,108(Suppl 1):4554-4561. |
[10] | ZHANG C,ZHANG M,WANG S,et al.Interactions between gut microbiota,host genetics and diet relevant to development of metabolic syndromes in mice[J]. ISME J,2010,4(2):232-241. |
[11] | LOZUPONE C A,STOMBAUGH J I,GORDON J I,et al.Diversity,stability and resilience of the human gut microbiota[J]. Nature,2012,489(7415):220-230. |
[12] | CLAESSON M J,CUSACK S,O'SULLIVAN O,et al. Composition,variability,and temporal stability of the intestinal microbiota of the elderly[J]. Proc Natl Acad Sci U S A,2011,108(Suppl 1):4586-4591. |
[13] | ZOETENDAL E G,RAES J,VAN DEN BOGERT B,et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates[J]. ISME J,2012,6(7):1415-1426. |
[14] | BIK E M,ECKBURG P B,GILL S R,et al.Molecular analysis of the bacterial microbiota in the human stomach[J]. Proc Natl Acad Sci U S A,2006,103(3):732-737. |
[15] | FRANZOSA E A,HUANG K,MEADOW J F,et al.Identifying personal microbiomes using metagenomic codes[J]. Proc Natl Acad Sci U S A,2015,112(22):E2930-E2938. |
[16] | ECKBURG P B,BIK E M,BERNSTEIN C N,et al.Diversity of the human intestinal microbial flora[J]. Science,2005,308(5728):1635-1638. |
[17] | QIN J,LI R,RAES J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature,2010,464(7285):59-65. |
[18] | MATSUKI T,WATANABE K,FUJIMOTO J,et al.Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces[J]. Appl Environ Microbiol,2004,70(12):7220-7228. |
[19] | FRANKS A H,HARMSEN H J,RAANGS G C,et al.Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes[J]. Appl Environ Microbiol,1998,64(9):3336-3345. |
[20] | VIJAY-KUMAR M,AITKEN J D,CARVALHO F A,et al.Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5[J]. Science,2010,328(5975):228-231. |
[21] | ZHANG W,HARTMANN R,TUN H M,et al.Deletion of the Toll-like receptor 5 gene per se does not determine the gut microbiome profile that induces metabolic syndrome:environment trumps genotype[J]. PLoS One,2016,11(3):e0150943. |
[22] | BÄCKHED F,MANCHESTER J K,SEMENKOVICH C F,et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J]. Proc Natl Acad Sci U S A,2007,104(3):979-984. |
[23] | ALANG N,KELLY C R. Weight gain after fecal microbiota transplantation[J]. Open Forum Infect Dis,2015,2(1):ofv004. |
[24] | LEY R E,TURNBAUGH P J,KLEIN S,et al.Microbial ecology:human gut microbes associated with obesity[J]. Nature,2006,444(7122):1022-1023. |
[25] | LE CHATELIER E,NIELSEN T,QIN J,et al.Richness of human gut microbiome correlates with metabolic markers[J]. Nature,2013,500(7464):541-546. |
[26] | BOULANGE C L,NEVES A L,CHILLOUX J,et al.Impact of the gut microbiota on inflammation,obesity,and metabolic disease[J]. Genome Med,2016,8(1):42. |
[27] | FAK F,TREMAROLI V,BERGSTRÖM G,et al. Oral microbiota in patients with atherosclerosis[J]. Atherosclerosis,2015,243(2):573-578. |
[28] | KARLSSON F H,FAK F,NOOKAEW I,et al.Symptomatic atherosclerosis is associated with an altered gut metagenome[J]. Nat Commun,2012,3:1245. |
[29] | PASINI E,AQUILANI R,TESTA C,et al.Pathogenic gut flora in patients with chronic heart failure[J]. JACC Heart Fail,2016,4(3):220-227. |
[30] | WANG Z,KLIPFELL E,BENNETT B J,et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature,2011,472(7341):57-63. |
[31] | KOETH R A,WANG Z,LEVISON B S,et al.Intestinal microbiota metabolism of L-carnitine,a nutrient in red meat,promotes atherosclerosis[J]. Nat Med,2013,19(5):576-585. |
[32] | SELDIN M M,MENG Y,QI H,et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB[J]. J Am Heart Assoc,2016,5(2):pii.e002767. |
[33] | ZHU W,GREGORY J C,ORG E,et al.Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell,2016,165(1):111-124. |
[34] | ZITVOGEL L,GALLUZZI L,VIAUD S,et al. Cancer and the gut microbiota:an unexpected link[J]. Sci Transl Med,2015,7(271):271ps1. |
[35] | LOUIS P,HOLD G L,FLINT H J.The gut microbiota,bacterial metabolites and colorectal cancer[J]. Nat Rev Microbiol,2014,12(10):661-672. |
[36] | BONNET M,BUC E,SAUVANET P,et al.Colonization of the human gut by E. coli and colorectal cancer risk[J]. Clin Cancer Res,2014,20(4):859-867. |
[37] | YANG J,TAN Q,FU Q,et al.Gastrointestinal microbiome and breast cancer:correlations,mechanisms and potential clinical implications[J]. Breast Cancer,2017,24(2):220-228. |
[38] | TANEJA V.Arthritis susceptibility and the gut microbiome[J]. FEBS Lett,2014,588(22):4244-4249. |
[39] | SCHER J U,SCZESNAK A,LONGMAN R S,et al.Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis[J]. Elife,2013,2:e01202. |
[40] | CHEN J,WRIGHT K,DAVIS J M,et al.An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis[J]. Genome Med, 2016,8(1):43. |
[41] | MARIETTA E V,MURRAY J A,LUCKEY D H,et al.Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice[J]. Arthritis Rheumatol, 2016, 68(12):2878-2888. |
[42] | OCHOA-REPARAZ J,KASPER L H.The second brain:is the gut microbiota a link between obesity and central nervous system disorders?[J]. Curr Obes Rep,2016,5(1):51-64. |
[43] | CRUMEYROLLE-ARIAS M,JAGLIN M,BRUNEAU A,et al.Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats[J]. Psychoneuroendocrinology,2014,42:207-217. |
[44] | COURY D L,ASHWOOD P,FASANO A,et al.Gastrointestinal conditions in children with autism spectrum disorder:developing a research agenda[J]. Pediatrics,2012,130(Suppl 2):S160-S168. |
[45] | KANG D W,PARK J G,ILHAN Z E,et al.Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children[J]. PLoS One,2013,8(7):e68322. |
[46] | HSIAO E Y,MCBRIDE S W,HSIEN S,et al.Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders[J]. Cell,2013,155(7):1451-1463. |
[47] | FASANO A,VISANJI N P,LIU L W,et al.Gastrointestinal dysfunction in Parkinson's disease[J]. Lancet Neurol,2015,14(6):625-639. |
[48] | KESHAVARZIAN A,GREEN S J,ENGEN P A,et al.Colonic bacterial composition in Parkinson's disease[J]. Mov Disord,2015,30(10):1351-1360. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||